EXAS vs TMP
EXACT Sciences Corporation (EXAS) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
EXAS currently screens at market cap $20.03B. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the EXAS and TMP stock pages for the full models.
Not investment advice.